Target Name: MIR646
NCBI ID: G693231
Review Report on MIR646 Target / Biomarker Content of Review Report on MIR646 Target / Biomarker
MIR646
Other Name(s): microRNA 646 | hsa-miR-646 | MicroRNA 646 | MIRN646 | hsa-mir-646

MiRNA 646: A Non-Coding RNA Molecule Regulating Gene Expression

MicroRNA (miRNA) 646 is a non-coding RNA molecule that plays a crucial role in regulating gene expression in various organisms, including humans. It is a part of the miRNA family, which consists of 21 non-coding RNAs that are approximately 20-22 amino acids in length. miRNA 646 is a unique molecule due to its length and specificity. It is one of the most well-studied miRNAs, and its function in various biological processes has been well-documented.

Molecular biology and gene expression

MiRNA 646 is a highly conserved molecule that is found in various organisms, including plants, animals, and bacteria. It is expressed in different cell types and has been shown to play a role in regulating gene expression. miRNA 646 is a good candidate for drug targets or biomarkers due to its unique structure and function.

Function and role in gene expression

MiRNA 646 is involved in the regulation of gene expression by targets a specific set of genes. It interacts with the protein miRNA-binding protein (miBP) to recruit miBP-bound target genes to the microtubules of the mitotic spindle. This interaction between miRNA 646 and miBP allows the miRNA 646 to target specific genes for regulation.

Studies have shown that miRNA 646 regulates a wide range of genes, including enzymes involved in cell growth and division, cell signaling pathways, and cell survival. It has been shown to regulate the expression of genes involved in cell adhesion, migration, and invasion. Additionally, miRNA 646 has been shown to play a role in the regulation of cell cycle progression, apoptosis, and inflammation.

Drug targeting

Drug targeting is a strategy that involves the use of small molecules or antibodies to selectively interact with a specific target molecule and inhibit its function. One of the goals of drug targeting is to treat diseases caused by the over-expression or under-expression of a particular gene.

MiRNA 646 is a potential drug target due to its unique structure and function. Its interaction with miBP allows it to target specific genes, and its role in regulating gene expression makes it an attractive target for small molecules or antibodies. Additionally, its length and specificity make it a good candidate for drug targeting.

Biomarkers

Biomarkers are molecules that are used to monitor or diagnose a specific disease or condition. They are often used in diagnostic tests and are also used to monitor the effectiveness of treatments.

MiRNA 646 could be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its expression has been shown to be affected by various diseases, including cancer, and its levels have been found to be decreased in the brains of patients with neurodegenerative diseases.

Conclusion

MiRNA 646 is a non-coding RNA molecule that plays a crucial role in regulating gene expression in various organisms. Its unique structure and function make it an attractive candidate for drug targets or biomarkers. Its role in regulating gene expression has been well-documented, and its potential as a drug target or biomarker is being actively explored. Further studies are needed to fully understand its function and potential as a drug target or biomarker.

Protein Name: MicroRNA 646

The "MIR646 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR646 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765